APP and Alzheimer disease: In terms of the ACH2.0, potentially, the activation of the AβPP-independent iAβ generation pathway can be precluded or its operation suppressed, and, accordingly, AD could be prevented or its progression stopped by the inhibition of the ISR, e.g., with the small molecule ISR inhibitor ISRIB.